India · Delayed Price · Currency is INR NSE:STARHEALTH Statistics
Total Valuation
NSE:STARHEALTH has a market cap or net worth of INR 340.39 billion. The enterprise value is 330.66 billion.
| Market Cap | 340.39B |
| Enterprise Value | 330.66B |
Important Dates
The last earnings date was Wednesday, July 29, 2026.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:STARHEALTH has 588.40 million shares outstanding. The number of shares has decreased by -0.71% in one year.
| Current Share Class | 588.40M |
| Shares Outstanding | 588.40M |
| Shares Change (YoY) | -0.71% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 16.11% |
| Owned by Institutions (%) | 28.89% |
| Float | 170.62M |
Valuation Ratios
The trailing PE ratio is 50.92 and the forward PE ratio is 23.69. NSE:STARHEALTH's PEG ratio is 0.95.
| PE Ratio | 50.92 |
| Forward PE | 23.69 |
| PS Ratio | 1.84 |
| PB Ratio | 3.36 |
| P/TBV Ratio | 3.36 |
| P/FCF Ratio | 18.96 |
| P/OCF Ratio | 18.17 |
| PEG Ratio | 0.95 |
Enterprise Valuation
| EV / Earnings | 49.46 |
| EV / Sales | 1.79 |
| EV / EBITDA | n/a |
| EV / EBIT | 36.52 |
| EV / FCF | 18.42 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.51% and return on invested capital (ROIC) is 7.34%.
| Return on Equity (ROE) | 7.51% |
| Return on Assets (ROA) | 2.53% |
| Return on Invested Capital (ROIC) | 7.34% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.33% |
| Revenue Per Employee | 9.95M |
| Profits Per Employee | 360,083 |
| Employee Count | 18,566 |
| Asset Turnover | 0.83 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:STARHEALTH has paid 2.39 billion in taxes.
| Income Tax | 2.39B |
| Effective Tax Rate | 26.37% |
Stock Price Statistics
The stock price has increased by +32.59% in the last 52 weeks. The beta is 0.20, so NSE:STARHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +32.59% |
| 50-Day Moving Average | 581.19 |
| 200-Day Moving Average | 505.03 |
| Relative Strength Index (RSI) | 47.12 |
| Average Volume (20 Days) | 525,993 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:STARHEALTH had revenue of INR 184.75 billion and earned 6.69 billion in profits. Earnings per share was 11.36.
| Revenue | 184.75B |
| Gross Profit | 40.56B |
| Operating Income | 9.06B |
| Pretax Income | 9.08B |
| Net Income | 6.69B |
| EBITDA | n/a |
| EBIT | 9.06B |
| Earnings Per Share (EPS) | 11.36 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 101.44B |
| Book Value Per Share | 172.35 |
| Working Capital | 5.53B |
Cash Flow
| Operating Cash Flow | 18.73B |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 17.95B |
| FCF Per Share | 30.51 |
Margins
Gross margin is 21.95%, with operating and profit margins of 4.90% and 3.62%.
| Gross Margin | 21.95% |
| Operating Margin | 4.90% |
| Pretax Margin | 4.91% |
| Profit Margin | 3.62% |
| EBITDA Margin | n/a |
| EBIT Margin | 4.90% |
| FCF Margin | 10.07% |
Dividends & Yields
NSE:STARHEALTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.71% |
| Shareholder Yield | 0.71% |
| Earnings Yield | 1.96% |
| FCF Yield | 5.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:STARHEALTH is 644.04, which is 11.33% higher than the current price. The consensus rating is "Buy".
| Price Target | 644.04 |
| Price Target Difference | 11.33% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 16.15% |
| EPS Growth Forecast (3Y) | 52.88% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |